Contact: Kim Treanor 202-332-2670; kim.treanor@keionline.org January 5, 2018 The National Institutes of Health (NIH) has proposed an exclusive license with Gilead for certain patent applications for inventions that target CD-30 proteins and CAR T technologies. The proposed license is to… Continue Reading
The NIH has filed a motion to dismiss in our lawsuit over the NIH license of CAR T patents to Gilead. See original KEI complaint here: https://www.keionline.org/27669. As expected, the NIH is challenging KEI’s standing. KEI has 15 days to… Continue Reading
Walgreen and Kroger, two major U.S. pharmacies, have filed suit against Johnson & Johnson in the U.S. District Court Eastern District of Pennsylvania, alleging antitrust violations stemming from exclusionary contracts and rebates designed to prevent biosimilars of J&J’s Remicade (INN:… Continue Reading
KEI has joined unions, NGOs and payors on a letter sent to Senator Grassley and Sen. Feinstein, the chair and ranking member of the Judiciary Committee, thanking them for their support of the Creating and Restoring Equal Access to Equivalent… Continue Reading
UPDATE: On 29 May 2018, Brazil and India notified the WTO secretariat to be “added to the list of sponsors of the submission circulated in document IP/C/W/643”. (Source: IP/C/W/643/Add.1). On 25 May 2018, the World Trade Organization (WTO) published a… Continue Reading
At the 71st World Health Assembly, KEI will deliver the following intervention regarding the Draft thirteenth general programme of work, 2019–2023. Strategic priority matters 11.1 Draft thirteenth general programme of work, 2019–2023 KEI endorses the WHO’s unwavering commitment to universal… Continue Reading
At the 71st World Health Assembly, KEI will deliver the following intervention regarding the Preparation for the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases, to be held in 2018. 11.7 Preparation for… Continue Reading
At the 71st World Health Assembly, KEI will deliver the following intervention regarding the Global Strategy and Plan of Action on Public Health, Innovation, and Intellectual Property: 11.6 Global strategy and plan of action on public health, innovation and intellectual… Continue Reading
21 May 2018 Knowledge Ecology International (KEI) intends to deliver the following statement on Addressing the global shortage of, and access to, medicines and vaccines. 11.5 Addressing the global shortage of, and access to, medicines and vaccines Documents A71/12 and… Continue Reading
On Wednesday, 23 May 2018, Knowledge Ecology International and Stichting Health Action International (HAI) are convening a panel discussion on WHO’s Roadmap on Access to Medicines and Vaccines from 12h30 to 14h30 in Espace Henry Dunant at the Red Cross… Continue Reading
On Wed, May 16, 2018, the House Ways & Means Committee held a markup on HR. 5773, a bill dealing with the opioid crisis, which would require Medicare prescription drug plans to establish drug management programs for at-risk beneficiaries. Representative… Continue Reading